Catalyst Wire Dossier Catalyst Wire Dossier

rMenB±OMV NZ vaccine

meningococcal group B vaccine (rMenB±OMV NZ) · Novartis Vaccines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rMenB±OMV NZ vaccine, covering 2014-05-06 to 2014-05-06. Get the full timeline:

Most recent: Clinical Trial Update: Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Same Vaccine [Phase 2]

See pricing